This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Corden Pharma Intl

Profile

CordenPharma is the CDMO Partner you need for fully-integrated supply of complex modalities tailored for your innovative Tides lifecycle needs. Leveraging decades of experience across our Peptide, Lipid Excipient, and Injectable platforms, CordenPharma is now offering Oligonucleotide API manufacturing capabilities seamlessly integrated with Lipid NanoParticle (LNP) Formulation and Injectable Drug Product capacities.

We're bringing you

  • Green SPPS – An Effort to Minimize the Environmental Impact Related to the SPPS Process

    12:20pm